Advertisement

Index by author

November 01, 1984; Volume 26,Issue 3

A

  1. Ambler, S K

    1. The relationship between phosphatidylinositol metabolism and mobilization of intracellular calcium elicited by alpha1-adrenergic receptor stimulation in BC3H-1 muscle cells.
      S K Ambler, R D Brown and P Taylor
      Molecular Pharmacology November 1984, 26 (3) 405-413;

B

  1. Bachur, N R

    1. Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues.
      P L Gutierrez, B M Fox, M M Mossoba and N R Bachur
      Molecular Pharmacology November 1984, 26 (3) 582-586;

  2. Baker, J A

    1. Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.
      S Jaques, M C Tobes, J C Sisson, J A Baker and D M Wieland
      Molecular Pharmacology November 1984, 26 (3) 539-546;

  3. Belinsky, S A

    1. Reducing equivalents for mixed function oxidation in periportal and pericentral regions of the liver lobule in perfused livers from normal and phenobarbital-treated rats.
      S A Belinsky, F C Kauffman and R G Thurman
      Molecular Pharmacology November 1984, 26 (3) 574-581;

  4. Beuzard, Y

    1. Inhibition of erythrocyte sickling by thiol reagents.
      M C Garel, C Domenget, F Galacteros, J Martin-Caburi and Y Beuzard
      Molecular Pharmacology November 1984, 26 (3) 559-565;

  5. Blanchard, S G

    1. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
      K J Chang, S G Blanchard and P Cuatrecasas
      Molecular Pharmacology November 1984, 26 (3) 484-488;

  6. Brown, R D

    1. The relationship between phosphatidylinositol metabolism and mobilization of intracellular calcium elicited by alpha1-adrenergic receptor stimulation in BC3H-1 muscle cells.
      S K Ambler, R D Brown and P Taylor
      Molecular Pharmacology November 1984, 26 (3) 405-413;

C

  1. Chang, K J

    1. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
      K J Chang, S G Blanchard and P Cuatrecasas
      Molecular Pharmacology November 1984, 26 (3) 484-488;

  2. Chou, T C

    1. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
      T C Chou, C Lopez, J M Colacino, A Feinberg, K A Watanabe, J J Fox and F S Philips
      Molecular Pharmacology November 1984, 26 (3) 587-593;

  3. Colacino, J M

    1. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
      T C Chou, C Lopez, J M Colacino, A Feinberg, K A Watanabe, J J Fox and F S Philips
      Molecular Pharmacology November 1984, 26 (3) 587-593;

  4. Cooper, D M

    1. Progesterone inhibition of Xenopus oocyte adenylate cyclase is not mediated via the Bordetella pertussis toxin substrate.
      S E Sadler, J L Maller and D M Cooper
      Molecular Pharmacology November 1984, 26 (3) 526-531;

  5. Cuatrecasas, P

    1. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
      K J Chang, S G Blanchard and P Cuatrecasas
      Molecular Pharmacology November 1984, 26 (3) 484-488;

D

  1. De Léan, A

    1. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
      A De Léan, H Ong, J Gutkowska, P W Schiller and N McNicoll
      Molecular Pharmacology November 1984, 26 (3) 498-508;

  2. Domenget, C

    1. Inhibition of erythrocyte sickling by thiol reagents.
      M C Garel, C Domenget, F Galacteros, J Martin-Caburi and Y Beuzard
      Molecular Pharmacology November 1984, 26 (3) 559-565;

  3. Doss, R C

    1. Use of a density shift method to assess beta-adrenergic receptor synthesis during recovery from catecholamine-induced down-regulation in human astrocytoma cells.
      G L Waldo, R C Doss, J P Perkins and T K Harden
      Molecular Pharmacology November 1984, 26 (3) 424-429;

  4. Duax, W L

    1. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
      W L Duax, D C Swenson, P D Strong, K S Korach, J McLachlan and M Metzler
      Molecular Pharmacology November 1984, 26 (3) 520-525;

E

  1. Evans, T

    1. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
      T Evans, M M Smith, L I Tanner and T K Harden
      Molecular Pharmacology November 1984, 26 (3) 395-404;

F

  1. Feinberg, A

    1. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
      T C Chou, C Lopez, J M Colacino, A Feinberg, K A Watanabe, J J Fox and F S Philips
      Molecular Pharmacology November 1984, 26 (3) 587-593;

  2. Fleming, R M

    1. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.
      A C Howlett and R M Fleming
      Molecular Pharmacology November 1984, 26 (3) 532-538;

  3. Fox, B M

    1. Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues.
      P L Gutierrez, B M Fox, M M Mossoba and N R Bachur
      Molecular Pharmacology November 1984, 26 (3) 582-586;

  4. Fox, J J

    1. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
      T C Chou, C Lopez, J M Colacino, A Feinberg, K A Watanabe, J J Fox and F S Philips
      Molecular Pharmacology November 1984, 26 (3) 587-593;

G

  1. Galacteros, F

    1. Inhibition of erythrocyte sickling by thiol reagents.
      M C Garel, C Domenget, F Galacteros, J Martin-Caburi and Y Beuzard
      Molecular Pharmacology November 1984, 26 (3) 559-565;

  2. Garel, M C

    1. Inhibition of erythrocyte sickling by thiol reagents.
      M C Garel, C Domenget, F Galacteros, J Martin-Caburi and Y Beuzard
      Molecular Pharmacology November 1984, 26 (3) 559-565;

  3. Goldstein, D B

    1. Genetic influences on the central nervous system depressant and membrane-disordering actions of ethanol and sodium valproate.
      B J Perlman and D B Goldstein
      Molecular Pharmacology November 1984, 26 (3) 547-552;

  4. Gutierrez, P L

    1. Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues.
      P L Gutierrez, B M Fox, M M Mossoba and N R Bachur
      Molecular Pharmacology November 1984, 26 (3) 582-586;

  5. Gutkowska, J

    1. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
      A De Léan, H Ong, J Gutkowska, P W Schiller and N McNicoll
      Molecular Pharmacology November 1984, 26 (3) 498-508;

H

  1. Hancock, A A

    1. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
      A A Hancock and C L Marsh
      Molecular Pharmacology November 1984, 26 (3) 439-451;

  2. Harden, T K

    1. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
      T Evans, M M Smith, L I Tanner and T K Harden
      Molecular Pharmacology November 1984, 26 (3) 395-404;
    2. Use of a density shift method to assess beta-adrenergic receptor synthesis during recovery from catecholamine-induced down-regulation in human astrocytoma cells.
      G L Waldo, R C Doss, J P Perkins and T K Harden
      Molecular Pharmacology November 1984, 26 (3) 424-429;

  3. Holý, A

    1. The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes.
      J S Schanche, T Schanche, P M Ueland, A Holý and I Votruba
      Molecular Pharmacology November 1984, 26 (3) 553-558;

  4. Howlett, A C

    1. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.
      A C Howlett and R M Fleming
      Molecular Pharmacology November 1984, 26 (3) 532-538;

I

  1. Iwata, K

    1. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
      T Nakajima and K Iwata
      Molecular Pharmacology November 1984, 26 (3) 430-438;

J

  1. Jaques, S

    1. Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.
      S Jaques, M C Tobes, J C Sisson, J A Baker and D M Wieland
      Molecular Pharmacology November 1984, 26 (3) 539-546;

  2. Johnson, N

    1. Binding of [3H]naloxonazine to rat brain membranes.
      N Johnson and G W Pasternak
      Molecular Pharmacology November 1984, 26 (3) 477-483;

K

  1. Kauffman, F C

    1. Reducing equivalents for mixed function oxidation in periportal and pericentral regions of the liver lobule in perfused livers from normal and phenobarbital-treated rats.
      S A Belinsky, F C Kauffman and R G Thurman
      Molecular Pharmacology November 1984, 26 (3) 574-581;

  2. Korach, K S

    1. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
      W L Duax, D C Swenson, P D Strong, K S Korach, J McLachlan and M Metzler
      Molecular Pharmacology November 1984, 26 (3) 520-525;

L

  1. Linden, J

    1. Purification and characterization of (-)[125I]hydroxyphenylisopropyladenosine, an adenosine R-site agonist radioligand and theoretical analysis of mixed stereoisomer radioligand binding.
      J Linden
      Molecular Pharmacology November 1984, 26 (3) 414-423;

  2. Lopez, C

    1. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
      T C Chou, C Lopez, J M Colacino, A Feinberg, K A Watanabe, J J Fox and F S Philips
      Molecular Pharmacology November 1984, 26 (3) 587-593;

  3. Lu, L J

    1. Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo.
      L J Lu and K Randerath
      Molecular Pharmacology November 1984, 26 (3) 594-603;

M

  1. Maller, J L

    1. Progesterone inhibition of Xenopus oocyte adenylate cyclase is not mediated via the Bordetella pertussis toxin substrate.
      S E Sadler, J L Maller and D M Cooper
      Molecular Pharmacology November 1984, 26 (3) 526-531;

  2. Markstein, R

    1. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
      M P Seiler and R Markstein
      Molecular Pharmacology November 1984, 26 (3) 452-457;

  3. Marsh, C L

    1. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
      A A Hancock and C L Marsh
      Molecular Pharmacology November 1984, 26 (3) 439-451;

  4. Martin-Caburi, J

    1. Inhibition of erythrocyte sickling by thiol reagents.
      M C Garel, C Domenget, F Galacteros, J Martin-Caburi and Y Beuzard
      Molecular Pharmacology November 1984, 26 (3) 559-565;

  5. McLachlan, J

    1. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
      W L Duax, D C Swenson, P D Strong, K S Korach, J McLachlan and M Metzler
      Molecular Pharmacology November 1984, 26 (3) 520-525;

  6. McNicoll, N

    1. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
      A De Léan, H Ong, J Gutkowska, P W Schiller and N McNicoll
      Molecular Pharmacology November 1984, 26 (3) 498-508;

  7. Metzler, M

    1. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
      W L Duax, D C Swenson, P D Strong, K S Korach, J McLachlan and M Metzler
      Molecular Pharmacology November 1984, 26 (3) 520-525;

  8. Moloney, S J

    1. Effect of cytosolic components on the metabolism of the hydrazide iproniazid.
      M E Spearman, S J Moloney and R A Prough
      Molecular Pharmacology November 1984, 26 (3) 566-573;

  9. Mossoba, M M

    1. Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues.
      P L Gutierrez, B M Fox, M M Mossoba and N R Bachur
      Molecular Pharmacology November 1984, 26 (3) 582-586;

N

  1. Nakajima, T

    1. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
      T Nakajima and K Iwata
      Molecular Pharmacology November 1984, 26 (3) 430-438;

  2. North, R A

    1. Opiate-receptor interactions on single locus coeruleus neurones.
      J T Williams and R A North
      Molecular Pharmacology November 1984, 26 (3) 489-497;

O

  1. Ong, H

    1. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
      A De Léan, H Ong, J Gutkowska, P W Schiller and N McNicoll
      Molecular Pharmacology November 1984, 26 (3) 498-508;

P

  1. Pasternak, G W

    1. Binding of [3H]naloxonazine to rat brain membranes.
      N Johnson and G W Pasternak
      Molecular Pharmacology November 1984, 26 (3) 477-483;

  2. Perkins, J P

    1. Use of a density shift method to assess beta-adrenergic receptor synthesis during recovery from catecholamine-induced down-regulation in human astrocytoma cells.
      G L Waldo, R C Doss, J P Perkins and T K Harden
      Molecular Pharmacology November 1984, 26 (3) 424-429;

  3. Perlman, B J

    1. Genetic influences on the central nervous system depressant and membrane-disordering actions of ethanol and sodium valproate.
      B J Perlman and D B Goldstein
      Molecular Pharmacology November 1984, 26 (3) 547-552;

  4. Philips, F S

    1. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
      T C Chou, C Lopez, J M Colacino, A Feinberg, K A Watanabe, J J Fox and F S Philips
      Molecular Pharmacology November 1984, 26 (3) 587-593;

  5. Prough, R A

    1. Effect of cytosolic components on the metabolism of the hydrazide iproniazid.
      M E Spearman, S J Moloney and R A Prough
      Molecular Pharmacology November 1984, 26 (3) 566-573;

R

  1. Randerath, K

    1. Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo.
      L J Lu and K Randerath
      Molecular Pharmacology November 1984, 26 (3) 594-603;

S

  1. Sadler, S E

    1. Progesterone inhibition of Xenopus oocyte adenylate cyclase is not mediated via the Bordetella pertussis toxin substrate.
      S E Sadler, J L Maller and D M Cooper
      Molecular Pharmacology November 1984, 26 (3) 526-531;

  2. Schanche, J S

    1. The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes.
      J S Schanche, T Schanche, P M Ueland, A Holý and I Votruba
      Molecular Pharmacology November 1984, 26 (3) 553-558;

  3. Schanche, T

    1. The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes.
      J S Schanche, T Schanche, P M Ueland, A Holý and I Votruba
      Molecular Pharmacology November 1984, 26 (3) 553-558;

  4. Schiller, P W

    1. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
      A De Léan, H Ong, J Gutkowska, P W Schiller and N McNicoll
      Molecular Pharmacology November 1984, 26 (3) 498-508;

  5. Schwartz, A L

    1. Cellular pathways of galactose-terminal ligand movement in a cloned human hepatoma cell line.
      C F Simmons and A L Schwartz
      Molecular Pharmacology November 1984, 26 (3) 509-519;

  6. Seiler, M P

    1. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
      M P Seiler and R Markstein
      Molecular Pharmacology November 1984, 26 (3) 452-457;

  7. Simmons, C F

    1. Cellular pathways of galactose-terminal ligand movement in a cloned human hepatoma cell line.
      C F Simmons and A L Schwartz
      Molecular Pharmacology November 1984, 26 (3) 509-519;

  8. Sisson, J C

    1. Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.
      S Jaques, M C Tobes, J C Sisson, J A Baker and D M Wieland
      Molecular Pharmacology November 1984, 26 (3) 539-546;

  9. Smith, M M

    1. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
      T Evans, M M Smith, L I Tanner and T K Harden
      Molecular Pharmacology November 1984, 26 (3) 395-404;

  10. Snowman, A M

    1. Anxiolytic cyclopyrrolone drugs allosterically modulate the binding of [35S]t-butylbicyclophosphorothionate to the benzodiazepine/gamma-aminobutyric acid-A receptor/chloride anionophore complex.
      R R Trifiletti, A M Snowman and S H Snyder
      Molecular Pharmacology November 1984, 26 (3) 470-476;

  11. Snyder, S H

    1. Anxiolytic cyclopyrrolones zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepine receptors.
      R R Trifiletti and S H Snyder
      Molecular Pharmacology November 1984, 26 (3) 458-469;
    2. Anxiolytic cyclopyrrolone drugs allosterically modulate the binding of [35S]t-butylbicyclophosphorothionate to the benzodiazepine/gamma-aminobutyric acid-A receptor/chloride anionophore complex.
      R R Trifiletti, A M Snowman and S H Snyder
      Molecular Pharmacology November 1984, 26 (3) 470-476;

  12. Spearman, M E

    1. Effect of cytosolic components on the metabolism of the hydrazide iproniazid.
      M E Spearman, S J Moloney and R A Prough
      Molecular Pharmacology November 1984, 26 (3) 566-573;

  13. Strong, P D

    1. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
      W L Duax, D C Swenson, P D Strong, K S Korach, J McLachlan and M Metzler
      Molecular Pharmacology November 1984, 26 (3) 520-525;

  14. Swenson, D C

    1. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
      W L Duax, D C Swenson, P D Strong, K S Korach, J McLachlan and M Metzler
      Molecular Pharmacology November 1984, 26 (3) 520-525;

T

  1. Tanner, L I

    1. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
      T Evans, M M Smith, L I Tanner and T K Harden
      Molecular Pharmacology November 1984, 26 (3) 395-404;

  2. Taylor, P

    1. The relationship between phosphatidylinositol metabolism and mobilization of intracellular calcium elicited by alpha1-adrenergic receptor stimulation in BC3H-1 muscle cells.
      S K Ambler, R D Brown and P Taylor
      Molecular Pharmacology November 1984, 26 (3) 405-413;

  3. Thurman, R G

    1. Reducing equivalents for mixed function oxidation in periportal and pericentral regions of the liver lobule in perfused livers from normal and phenobarbital-treated rats.
      S A Belinsky, F C Kauffman and R G Thurman
      Molecular Pharmacology November 1984, 26 (3) 574-581;

  4. Tobes, M C

    1. Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.
      S Jaques, M C Tobes, J C Sisson, J A Baker and D M Wieland
      Molecular Pharmacology November 1984, 26 (3) 539-546;

  5. Trifiletti, R R

    1. Anxiolytic cyclopyrrolones zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepine receptors.
      R R Trifiletti and S H Snyder
      Molecular Pharmacology November 1984, 26 (3) 458-469;
    2. Anxiolytic cyclopyrrolone drugs allosterically modulate the binding of [35S]t-butylbicyclophosphorothionate to the benzodiazepine/gamma-aminobutyric acid-A receptor/chloride anionophore complex.
      R R Trifiletti, A M Snowman and S H Snyder
      Molecular Pharmacology November 1984, 26 (3) 470-476;

U

  1. Ueland, P M

    1. The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes.
      J S Schanche, T Schanche, P M Ueland, A Holý and I Votruba
      Molecular Pharmacology November 1984, 26 (3) 553-558;

V

  1. Votruba, I

    1. The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes.
      J S Schanche, T Schanche, P M Ueland, A Holý and I Votruba
      Molecular Pharmacology November 1984, 26 (3) 553-558;

W

  1. Waldo, G L

    1. Use of a density shift method to assess beta-adrenergic receptor synthesis during recovery from catecholamine-induced down-regulation in human astrocytoma cells.
      G L Waldo, R C Doss, J P Perkins and T K Harden
      Molecular Pharmacology November 1984, 26 (3) 424-429;

  2. Watanabe, K A

    1. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
      T C Chou, C Lopez, J M Colacino, A Feinberg, K A Watanabe, J J Fox and F S Philips
      Molecular Pharmacology November 1984, 26 (3) 587-593;

  3. Wieland, D M

    1. Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.
      S Jaques, M C Tobes, J C Sisson, J A Baker and D M Wieland
      Molecular Pharmacology November 1984, 26 (3) 539-546;

  4. Williams, J T

    1. Opiate-receptor interactions on single locus coeruleus neurones.
      J T Williams and R A North
      Molecular Pharmacology November 1984, 26 (3) 489-497;
Back to top

In this issue

Advertisement